Number of the records: 1
Activity and safety of crizotinib in patients with advanced clear-cell sarcoma with MET alterations: European Organization for Research and Treatment of Cancer phase II trial 90101 'CREATE'
Title Activity and safety of crizotinib in patients with advanced clear-cell sarcoma with MET alterations: European Organization for Research and Treatment of Cancer phase II trial 90101 'CREATE' Author info Šufliarsky J. ... [et al.] Co-authors Šufliarsky Jozef
Corporation Redakcia Onkológia
Note Annals of oncology, May 5 (2018) Sign. C 3069 Source Onkológia. - ISSN 1336-8176. - Bratislava : SOLEN , 2018 . - Roč. 13, č. 3 (2018), s. 222 MeSH Subject sarkóm svetlobunkový : farmakoterapia
Subj. Headings krizotinib Language English Country Slovak Republic Document kind Rozpis článkov z periodík Database ARTICLES 
article
Number of the records: 1